A Study to Assess Injection Comfort of Two Formulations of ATX-101
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To assess the safety and injection comfort of ATX-101-BA versus ATX-101-BA-free immediately
following injection and at regular intervals up to 24-hours post-injection following
subcutaneous administration into the submental area.